A Study to Look at Performance of MICRUSFRAME and GALAXY Coils for the Treatment of Intracranial Aneurysms

Launched by CERENOVUS, PART OF DEPUY SYNTHES PRODUCTS, INC. · Aug 21, 2018

Keywords

ClinConnect Summary

This clinical trial is studying the use of two types of coils, called MICRUSFRAME and GALAXY, to treat brain aneurysms. An aneurysm is a weak spot in a blood vessel in the brain that can either be ruptured (burst) or unruptured (not burst). The goal of this study is to see how effective these coils are in treating both types of aneurysms.

To participate in the trial, you need to be between 21 and 80 years old and have a specific type of aneurysm that can be safely treated with these coils. You should also be willing to follow the study guidelines and attend follow-up appointments. It's important to note that if you have multiple aneurysms needing treatment or a certain type of aneurysm called fusiform, you would not be eligible to join. Participants can expect to receive these coils during their treatment and will be monitored closely to assess the outcomes.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Patient is between 21 and 80 years of age
• • 2. Patient has an intracranial saccular aneurysm, ruptured or unruptured, suitable for embolization with coils
• • 3. Patient is able and willing to comply with protocol and follow-up requirements
• Exclusion Criteria:
• • 1. Pre-planned staged procedure on unruptured aneurysm
• • 2. More than one aneurysm requiring treatment during the course of study
• • 3. Fusiform aneurysm